Processa Pharmaceuticals, Inc. ($PCSA)
Lin Patrick โ Chief Business - Strategy Off
Shares
1,603
Price
$2.54
Total Value
$4,063.61
P&L
+22.3% (+$905.69)
Nearby Earnings
Mar 19, 2026
EPS:-1.31 (est: -1.25)+4.5%
Transaction Details
| Insider | Lin Patrick |
|---|---|
| Title | Chief Business - Strategy Off |
| Transaction Date | Mar 31, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Apr 1, 2026 |
| Shares Purchased | 1,603 |
| Price per Share | $2.54 |
| Total Value | $4,063.61 |
| Shares Owned After | 3,356 |
| Derivative | No |
| Accession Number | 0000897069-26-000747 |
| Document | View SEC Filing |